The Guiding Role of Pharmaceutical Care in the Rational Drug Use of Bronchial Asthma

Source:
By:Hongmei Chen

DOI: https://doi.org/10.30564/jim.v8i1.991

Abstract:

Objective: To investigate the guiding role of pharmaceutical care in the treatment of bronchial asthma. Methods: Eighty patients with bronchial disease admitted to our hospital from November 2008 to December 1818 were enrolled in this research. The computer program was used to generate random numbers. The method was divided into two groups: control group and observation group, 40 cases respectively. 40 patients in the control group were treated with normal medication according to the doctor's advice; 40 patients in the observation group were enrolled in the pharmacological care on the basis of the control group, and the rational drug use was compared between the two groups. Results: The incidence of adverse reactions in the observation group and the control group were 5.00% and 17.50%, respectively, and the difference was statistically significant (P<0.05); the incidence of medication error events in the observation group was 7.50%, which was significantly lower than that of the control group, which was 25.00%, and the difference was statistically significant (P<0.05). The medication errors mainly include improper administration, incorrect dosage, and unscientific administration. Conclusion: The guiding role of pharmaceutical care in bronchial asthma rational drug use can reduce medication error events and ensure rational drug use, which is worthy of popularization in clinical practice.

References:

[1] Jianping Li. Clinical application of pharmaceutical care and rational drug use in the treatment of bronchial asthma[J]. Chinese Journal of Clinical Rational Drug Use, 2016, 9(21): 46-47. (in Chinese) [2] Zhong Meng, Xiaoying Zhu. Pharmaceutical care of bronchial asthma with pulmonary infection in 1 case[J]. Chinese Journal of Clinical Rational Drug Use, 2015(11): 164-165. (in Chinese) [3] Li Zhang, He Shu, Zhe Wang, et al. Pharmaceutical care of bronchial asthma patients with bronchodilators[J]. Chinese Journal of Drug Application and Monitoring, 2015(1). (in Chinese) [4] Hairui Zhang. Analysis of rational drug use in patients with chronic obstructive pulmonary disease with overlapping bronchial asthma[J]. Henan Medical Research, 2016, 25(10): 1862-1863. (in Chinese) [5] Bing Wang, Li Gao, Mingjie Sun. Case analysis of an elevated blood glucose in patients with bronchial asthma caused by methylprednisolone[J]. Journal of harmaceutical Research, 2015(8): 483-484. (in Chinese) [6] Yongmei Lu. Rational application of pharmaceutical care to promote stroke Chinese patent medicines[J].Journal of Clinical Rational Drug Use, 2018, 11(35):126-127. (in Chinese) [7] Yanhua Zhu, Huirong Ma, Eskandar Umar. Clinical pharmacists involved in pharmaceutical care of hospitalized patients with bronchial asthma[J]. Evaluation and Analysis of Drug-Use in Hospitals of China,2016(3): 421-423. (in Chinese) [8] Qiaotian Cheng, Ruicai Hong, Yanting Yang. Application value of pharmaceutical care in guiding bronchial asthma rational drug use[J]. Chinese Journalof Modern Drug Application, 2018(1): 149-150. (in Chinese) [9] Junhua Xu. Application of pharmaceutical care in the treatment of long-term inhaled corticosteroids in children with bronchial asthma[J]. Journal of Clinical Rational Drug Use, 2018, 11(27): 107-108. (in Chinese) [10] Na Liu, Jiqiu Hou. Pharmaceutical care of patients with bronchial asthma complicated with pulmonary embolism and pulmonary infection[J]. Evaluation and Analysis of Drug-Use in Hospitals of China,2017(4). (in Chinese) [11] Xinghai Ma. Analysis of Pharmacy Service and Clinical Effect of Patients with Bronchial Asthma[J].World Latest Medicine Information, 2016, 16(58):205-205. (in Chinese) [12] Shuhua Zhao. Pharmaceutical care of 100 patients with bronchial asthma complicated with hypertension[J]. Knowledge of Cardiovascular Disease Prevention (Academic Edition), 2016(3): 43-45. (in Chinese) [13] Qi Lin, Bijin Zheng, Lili Zheng, et al. Pharmacyutical care of oxygen-driven aerosol inhalation in adult patients with bronchial asthma[J]. Strait Pharmaceutical Journal, 2014(6): 98-99. (in Chinese) [14] Yifang Zhang, Guoqin Lao, Jie Jiang. Pharmaceutical care of a patient with allergic bronchopulmonary aspergillosis[J]. Chinese Journal of Drug Application and Monitoring, 2015(1): 30-32. (in Chinese)